Publicaciones en las que colabora con JESUS FRANCISCO BERMEJO MARTIN (40)

2024

  1. Quantification of bacterial DNA in blood using droplet digital PCR: a pilot study

    Diagnostic Microbiology and Infectious Disease, Vol. 108, Núm. 1

  2. Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19

    International Journal of Infectious Diseases, Vol. 140, pp. 132-135

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

2022

  1. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240

  2. N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study

    Clinical Microbiology and Infection, Vol. 28, Núm. 10, pp. 1391.e1-1391.e5

2021

  1. Combining immunomodulators and antivirals for COVID-19 – Authors' reply

    The Lancet Microbe

  2. Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma

    European Journal of Clinical Investigation, Vol. 51, Núm. 6

  3. Mounting evidence of impaired viral control in severe COVID-19

    The Lancet Microbe

2020

  1. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

    Critical Care, Vol. 24, Núm. 1

2017

  1. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity

    Annals of Intensive Care, Vol. 7, Núm. 1

2016

  1. Defining immunological dysfunction in sepsis: A requisite tool for precision medicine

    Journal of Infection, Vol. 72, Núm. 5, pp. 525-536

  2. Impact of ventilator-associated pneumonia on mortality and epidemiological features of patients with secondary peritonitis

    Annals of Intensive Care, Vol. 6, Núm. 1

  3. Postbooster antibodies from humans as source of diphtheria antitoxin

    Emerging Infectious Diseases, Vol. 22, Núm. 7, pp. 1265-1267

  4. Procalcitonin cannot be used as a biomarker of infection in heart surgery patients with acute kidney injury

    Journal of Critical Care, Vol. 33, pp. 233-239

2015

  1. Preventing sepsis

    The Lancet Infectious Diseases

  2. Sustained value of proadrenomedullin as mortality predictor in severe sepsis

    Journal of Infection

  3. The original sins of clinical trials with intravenous immunoglobulins in sepsis

    Critical Care

  4. Transcriptomic correlates of organ failure extent in sepsis

    Journal of Infection, Vol. 70, Núm. 5, pp. 445-456

2014

  1. Hyperimmune serum from healthy vaccinated individuals for Ebola virus disease?

    The Lancet Global Health

  2. Quantification of IgM molecular response by droplet digital PCR as a potential tool for the early diagnosis of sepsis

    Critical Care